Table III.
Gene | Forward primer | Reverse primer |
---|---|---|
COL5A1 | 5′-TGTATTTCCCCTGACCTTCA-3′ | 5′-ACCTTTAATCCATCGGGAAG-3′ |
CTGF | 5′-TTTGGCCCAGACCCAACTAT-3′ | 5′-GTGCAGCCAGAAAGCTAAA-3′ |
ITGB2 | 5′-ACAAGCTGGCTGAAAACAAC-3′ | 5′-GCAGAAGGAGTCGTAGGTGA-3′ |
KAL1 | 5′-CAGCAAACACTTCCGTTCTT-3′ | 5′-GCTTCTTCTTTGTTGGGACA-3′ |
LAMA3 | 5′-CTGCCAGTGCATCTGAATCT-3′ | 5′-TTTCTGACCATGCTCTTTGC-3′ |
MMP2 | 5′-TTGACGGTAAGGACGGACTC-3′ | 5′-ACTTGCAGTACTCCCCATCG-3′ |
MMP7 | 5′-AGCCAAACTCAAGGAGATGC-3′ | 5′-GCCAATCATGATGTCAGCAG-3′ |
MMP12 | 5′-ACACATTTCGCCTCTCTGCT-3′ | 5′-CCTTCAGCCAGAAGAACCTG-3′ |
MMP13 | 5′-TGACCCTTCCTTATCCCTTG-3′ | 5′-ATACGGTTGGGAAGTTCTGG-3′ |
SPARC | 5′-GCACGGACTGTCAGTTCTCT-3′ | 5′-AAGAACAACCGATTCACCAA-3′ |
THBS3 | 5′-ACACAGTTCTCCTGCGACTC-3′ | 5′-ATGGACCCACCCAGAATAAT-3′ |
VCAN | 5′-TTGCTGTGGAAGGAACTGAG-3′ | 5′-CATAGGTGGCAGAAGCAGAA-3′ |
COL5A1, collagen type V α 1; CTGF, connective tissue growth factor; ITGB2, integrin, β 2; KAL1, kallmann syndrome 1 sequence; LAMA3, laminin α 3; MMP, matrix metallopeptidase; SPARC, secreted protein acidic, cysteine-rich; THBS3, Thrombospondin 3; and VCAN, Versican.